These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 7656145

  • 21. Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo.
    Yue TL, Rabinovici R, Farhat M, Feuerstein G.
    J Lipid Mediat; 1991; 3(1):13-26. PubMed ID: 1768837
    [Abstract] [Full Text] [Related]

  • 22. New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists.
    Braquet P, Esanu A.
    Agents Actions; 1991 Jan; 32(1-2):34-6. PubMed ID: 2058466
    [No Abstract] [Full Text] [Related]

  • 23. Presence of specific platelet-activating factor binding sites in the rat retina.
    Thierry A, Doly M, Braquet P, Cluzel J, Meyniel G.
    Eur J Pharmacol; 1989 Apr 12; 163(1):97-101. PubMed ID: 2545464
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.
    Beauchamp MH, Marrache AM, Hou X, Gobeil F, Bernier SG, Lachapelle P, Abran D, Quiniou C, Brault S, Peri KG, Roberts J, Almazan G, Varma DR, Chemtob S.
    Invest Ophthalmol Vis Sci; 2002 Oct 12; 43(10):3327-37. PubMed ID: 12356842
    [Abstract] [Full Text] [Related]

  • 30. Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats.
    de la Cruz JP, Moreno A, Ruiz-Ruiz MI, García-Campos J, Sánchez de la Cuesta F.
    Eur J Pharmacol; 1998 Oct 30; 360(1):37-42. PubMed ID: 9845270
    [Abstract] [Full Text] [Related]

  • 31. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
    Yue TL, Gleason MM, Gu JL, Lysko PG, Hallenbeck J, Feuerstein G.
    J Pharmacol Exp Ther; 1991 Apr 30; 257(1):374-81. PubMed ID: 1850473
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
    Ammit AJ, O'Neill C.
    Lipids; 1991 Dec 30; 26(12):1189-92. PubMed ID: 1668116
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor.
    Filep JG, Hermán F, Földes-Filep E, Schneider F, Braquet P.
    Br J Pharmacol; 1992 Apr 30; 105(4):912-8. PubMed ID: 1324056
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Platelet-activating factor antagonists (BN 52021 and BN 50730) inhibit tumor necrosis factor-alfa-mediated cytotoxicity on murine L929 tumor cells.
    Hunyadi J, Kenderessy AS, Duda E, Braquet P, Dobozy A.
    Mol Immunol; 1993 Apr 30; 30(6):517-9. PubMed ID: 7683748
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.